Polymer therapeutics in surgery: the next frontier
- PMID: 27588210
- PMCID: PMC4985703
- DOI: 10.1002/jin2.6
Polymer therapeutics in surgery: the next frontier
Abstract
Polymer therapeutics is a successful branch of nanomedicine, which is now established in several facets of everyday practice. However, to our knowledge, no literature regarding the application of the underpinning principles, general safety, and potential of this versatile class to the perioperative patient has been published. This study provides an overview of polymer therapeutics applied to clinical surgery, including the evolution of this demand-oriented scientific field, cutting-edge concepts, its implications, and limitations, illustrated by products already in clinical use and promising ones in development. In particular, the effect of design of polymer therapeutics on biophysical and biochemical properties, the potential for targeted delivery, smart release, and safety are addressed. Emphasis is made on principles, giving examples in salient areas of demand in current surgical practice. Exposure of the practising surgeon to this versatile class is crucial to evaluate and maximise the benefits that this established field presents and to attract a new generation of clinician-scientists with the necessary knowledge mix to drive highly successful innovation.
Keywords: nanomedicine; nanotechnology; polymer.
Figures
Similar articles
-
Polymer therapeutics at a crossroads? Finding the path for improved translation in the twenty-first century.J Drug Target. 2017 Nov-Dec;25(9-10):759-780. doi: 10.1080/1061186X.2017.1358729. Epub 2017 Aug 8. J Drug Target. 2017. PMID: 28783978 Review.
-
Nanomedicine: a new frontier in cancer therapeutics.Curr Drug Deliv. 2011 May;8(3):245-53. doi: 10.2174/156720111795256110. Curr Drug Deliv. 2011. PMID: 21291378
-
Clinically advancing and promising polymer-based therapeutics.Acta Biomater. 2018 Feb;67:1-20. doi: 10.1016/j.actbio.2017.11.044. Epub 2017 Dec 13. Acta Biomater. 2018. PMID: 29246651 Review.
-
Polymer therapeutics: Top 10 selling pharmaceuticals - what next?J Control Release. 2014 Sep 28;190:371-80. doi: 10.1016/j.jconrel.2014.05.001. Epub 2014 May 10. J Control Release. 2014. PMID: 24818766 Review.
-
Nanotechnology and nanomedicine: going small means aiming big.Curr Pharm Des. 2010 Jun;16(16):1882-92. doi: 10.2174/138161210791208992. Curr Pharm Des. 2010. PMID: 20222866 Review.
Cited by
-
An Accessible Method to Improve the Stability and Reusability of Porcine Pancreatic α-Amylase via Immobilization in Gellan-Based Hydrogel Particles Obtained by Ionic Cross-Linking with Mg2+ Ions.Molecules. 2023 Jun 11;28(12):4695. doi: 10.3390/molecules28124695. Molecules. 2023. PMID: 37375250 Free PMC article.
References
-
- Allison, D. D. , and Grande‐Allen K. J.. 2006. Review. Hyaluronan: a powerful tissue engineering tool. Tissue Eng. 12(8):2131–2140. - PubMed
-
- Ascher, B. , Bayerl C., Brun P. et al. 2011. Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of severe nasolabial lines – 6‐month interim results of a randomized, evaluator‐blinded, intra‐individual comparison study. J. Cosmet. Dermatol. 10(2):94–98. - PubMed
-
- Azzopardi, EA . Bioresponsive dextrin–colistin conjugates as antimicrobial agents for the treatment of Gram‐negative infection. Cardiff University, 2013a.
-
- Azzopardi, EA . Bioresponsive dextrin–colistin conjugates as antimicrobial agents for the treatment of Gram‐negative infection. Wound Biology Group, College of Medicine, Vol. PhD. Cardiff: Cardiff University, 2013b. pp. 250.
-
- Azzopardi, E. A. , Boyce D. E., Thomas D. W. et al. 2013. Colistin in burn intensive care: back to the future? Burns 39(1):7–15. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources